NeurAxis IB-Stim (01-1020)
Non-Implanted Nerve Stimulator For Pain Associated With Irritable Bowel Syndrome (Ibs). 510(k) K250451, from Neuraxis (Carmel, IN). Product code QHH, class 2.
As of Nov 21, 2026, K250451 is an FDA 510(k) held by Neuraxis, substantially equivalent on May 15, 2025 after 86 days, with no recalls tied to it in FDA's recall database.
- Review time: 86 days
- Recalls: 0
- Cited as a predicate by: 1 device
The IB-Stim is a percutaneous electrical nerve field stimulator (PENFS) system intended to be used in patients 8-21 years of age with functional abdominal pain associated with irritable bowel syndrome (IBS) and functional dyspepsia (FD).
- NeurAxis IB-Stim (01-1020)K241533 · Neuraxis · Oct 30, 2024
- NeurAxis IB-Stim (01-1020)K252024 · Neuraxis · Oct 16, 2025
- NeurAxis IB-Stim (01-1020)K252024 · Neuraxis · Oct 16, 2025
- NeurAxis IB-Stim (01-1020)K241533 · Neuraxis · Oct 30, 2024
- TEA DeviceK230526 · Transtimulation Research, Inc. · Sep 14, 2023
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Feb 18, 2025
- Review panel
- Gastroenterology, Urology
- Regulation
- 21 CFR 876.5340
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files